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550a Tuesday, February 18, 2014channels (MSCs) in the breast cancer cell line MCF7 with patch clamp
methods.
MSCs were present in 132 out of 258 cell-attached membrane patches. MSCs
could be activated by negative pressure at the outer side of the membrane in a
saturable manner (EP50: 41.2 5 0.5 mbar (N=13).When Kþ was predomi-
nantly present in the extracellular pipette solution, single channel conductance
exerted to be 25.65 0.4 pS (N=8). When complete ion selectivity was assessed,
conductivity was found to increase in the following order: Liþ < Naþ <
KþzRbþz Csþ. Furthermore, conductivity was smaller for divalent cations
(100 mmole/L compared to 153 mmole/L) with the order: Ca2þ< Ba2þ<Kþ
z Rb þ z Cs þ. We compared the biophysical properties of MSCs with
a recently discovered mechanosensitive cation channel, the human Piezo1
protein, heterologously overexpressed in HEK293 cells. Single channel con-
ductances were indistinguishable between MSCs from MCF7 and hPiezo1 in
HEK293 cells, both when 100% K þ and 50% K þ / 50% Na þ were used
as permeant ions.
MSCs occur in MCF7 breasts cancer cells, providing a sensorium for mechan-
ical stress. Ion selectivity studies show that divalents like Ca2þ can permeate to
a considerable extend. Moreover, permeation of monovalents is apparently
restricted by the size of the ions hydrate shell, as indicated by the smaller con-
ductivities for Na þ and Li þ, respectively, indicating that the ion permeation
mechanism through MSCs may be different to the cation channels crystallized
so far.
This research is supported by grants from the Austrian Research Foundation
(FWF22974 (WS); KLIF182 (TB)).
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Diaryldiamidines, a class of DNA minor groove binders used clinically since
the 1940s in the treatment of tropical parasitoses such as trypanosomiasis,
leishmaniasis, pneumocystis pneumonia and babesiosis, have been recently
found to exert specific blocking effects on acid-sensing ion channels (ASIC),
raising hopes to develop new small molecule neuroprotective agents for
ischemic stroke, which involves acidosis-mediated activation of ASIC1a and
heteromeric ASIC1a/2b channels. Therefore we have thoroughly investigated
the modes of interaction of diminazene with ASIC1a via whole-cell and
single-channel recordings on outside-out patches excised from HEK293 cells
of ASIC1a transient currents evoked by brief acidic pulses (pH 6.0). Data
idealization and model-dependent fitting were performed with custom hidden
Markov model maximum likelihood algorithms. We proved that the 3 subcon-
ductance levels are due to partial block by calcium of the permeation pathway,
and expanded our previous 8-state linear connectivity gating model (Marin
et al. 2008 Channels 2(6):1-10) including 3 subconductance states for each
of the 2 gating modes. Single-channel recordings with diminazene 0.6 or
3 mM indicated a mechanism of open channel block. By exponential fits of
the distributions of blocked and unblocked periods for each gating mode
we computed binding and unbinding rates and dissociation constants of 0.13
and 0.27 mM for gating modes 2 and 1, respectively. Using atomic resolution
models of human ASIC1a in the open conformations corresponding to the 2
gating modes, we found via molecular docking several intra- and intersubunit
binding sites for diminazene. One of these sites, assumed to be responsible for
the state-dependent block, features protrusion of the drug in the transmembrane
domain permeation pathway. As expected, for this blocking site the interaction
energy is higher in the symmetrical open conformation of the second gating
mode than in the asymmetrical open conformation of the first gating mode.
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GABA(A) receptors are critical for proper transmission of inhibitory signals in
the central nervous system, and are common targets of anesthetic and anxiolytic
drugs. Several naturally occurring mutations in such receptors can cause an
increased likelihood of seizures. In particular, gamma-K289M on the M2-M3
loop attached to the pore-lining M2 helices is associated with Generalized
Epilepsy and Febrile Seizures. At the single channel level, the mutation dramat-
ically reduces current amplitude in some subspecies, and increases deactivation
rate in other subspecies. The molecular mechanism through which the mutation
causes these effects is unknown. Using a homology model of the GABA(A) re-ceptor based on the recently solved structure for the homologous glutamate-
gated chloride channel (GluCl), we ran molecular dynamics simulations of
multiple replicas incorporating both the Wild-type and the mutation, at room
temperature and at temperatures inducing febrile seizures. We find distinct
effects of temperature on the mutant for some conformational variables,
including those governing the pore radius. From these results we propose a
molecular mechanism for rapid but unstable closure of GABA(A) receptors,
which would be likely to cause flickering in single channel recordings.
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In skeletal muscle the resting chloride conductance (gCl), sustained by the
ClC-1 chloride channel, controls the sarcolemma electrical stability. Resting
gCl is negatively regulated by Protein Kinase C (PKC), since its pharmacolog-
ical activation closes the ClC-1 channel. A reduced activity of PKC contributes
to the low gCl typical of slow-twitch muscles compared to the fast ones.
Different PKC isoforms are expressed in skeletal muscle, including the novel
isoform PKC-theta, where it mediates various cellular responses. Here we
investigated the role of PKC-theta in the regulation of ClC-1 channel activity
and expression in extensor digitorum longus (EDL) and in soleus (Sol) muscles,
using two models of PKC-theta null mice: a PKC-theta knockout model, in
which the PKC-theta gene was inactivated and the mPKC-theta-K/R transgenic
model, in which a dominant-negative mutant form of PKC-theta is expressed
under a muscle-specific promoter control. Electrophysiological studies showed
a gCl increase in Sol and EDL muscle of KO mice with respect to wild-type.
Muscle excitability was reduced accordingly. Similar effects were observed
in mPKC-theta-K/R mice. By using chelerythrine, a non-specific PKC inhibi-
tor, we demonstrated that other PKC isoforms present in skeletal muscle of
PKC-theta null mice are able to further modulate gCl. In parallel, we found
that the expression of the ClC-1 channel, evaluated by RT-PCR, was not modi-
fied either in EDL or in Sol of PKC-theta-KO mice, demonstrating that PKC-
theta does not control the ClC-1 expression but its activity. These results as well
as the modification of calcineurin and myocyte-enhancer-factor-2 expression
demonstrate the involvement of PKC-theta in the control of muscle phenotype.
We conclude that PKC-theta plays a role in regulating ClC-1 chloride channel
activity and skeletal muscle function. (ASI-OSMA).
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Rheumatoid arthritis (RA) is a chronic autoimmune disease that mainly affects
synovial joints, resulting in cartilage and bone degradation. Current therapies
for RA typically focus on suppressing the immune response, although resident
joint cells known as fibroblast-like synoviocytes (FLS) are responsible for
many of the pathogenic features of RA. In normal joints, FLS line the capsule
and function to maintain the extracellular matrix and to lubricate the joint.
However, FLS in RA (RA-FLS) develop an invasive phenotype tightly corre-
lated with joint damage and release proteases and pro-angiogenic and pro-
inflammatory growth factors. Due to their pathogenic nature, understanding
how to regulate RA-FLS activity could provide the basis for novel therapeutics
for RA that would bypass the need for immunosuppressants.
We have found that the KCa1.1 channels are involved in many of the patho-
genic features of RA-FLS. KCa1.1 is up-regulated in RA-FLS and localizes
on the leading edge of the plasma membrane. Blocking KCa1.1 ex vivo inhibits
cellular migration and invasion, along with the production of VEGF, IL-8, and
MMP-2. This inhibition in cellular motility agrees with our finding that block-
ing KCa1.1 inhibits the formation of lamellipodia and interferes with integrin
regulation in RA-FLS. These changes in phenotype are likely due to a calcium
transient that forms as a result of KCa1.1 block, as invasiveness of KCa1.1-
blocked RA-FLS is rescued upon blocking CaV channels on the cell membrane.
We have also found that blocking KCa1.1 with the small molecule paxilline
significantly decreases clinical signs in two complementary rat models of RA.
Tuesday, February 18, 2014 551aOur results point to KCa1.1 channels as a promising new target for RA
therapy and open the possibility for treatments that would not induce
immunosuppression.
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Voltage-gated Kþ channels (Kv) are responsible for myoblasts proliferation
and differentiation by triggering changes in membrane potential and cell
volume. Since individuals with myotonic dystrophy type 1 (DM1) display
reduced myogenesis led by prolonged myoblasts proliferation and delayed
myotubes fusion, we investigated the roles of Kþ channels in primary human
myoblasts obtained from DM1 patients and healthy volunteers. DM1 is an
autosomal dominant neuromuscular disorder affecting 1 in 8000 people world-
wide. It is the most common adult-onset muscular dystrophy and currently
has no treatment. DM1 is characterized by muscle wasting and multi-system
disorders.
We have identified a switch in functional potassium channel expression from
KCa1.1 to Kv1 channels when comparing myoblasts from healthy individuals
to myoblasts from patients with DM1. We showed increase in Kv1.2 and Kv1.5
channels, and decrease in KCa1.1 channels in DM1 myoblasts at mRNA level
by RT-PCR, at protein level by immunofluorescence, and at channel activity
by patch-clamp technique. We hypothesized that this switch in Kþ channels
plays a role in the reduced myogenesis observed in patients with DM1, and
that selective inhibition of Kv1 channels rescues the pathological features of
DM1 in skeletal muscle.
We show that pharmacological inhibition of Kv1 channels in DM1 myoblasts
normalized proliferation, rescued matrix metalloproteinase-2 (MMP-2, a
protease necessary for myotube fusion) production, and partially rescued
myotube fusion shown as increase in fusion index. On the contrary, selective
inhibition of KCa1.1 in normal myoblasts lowered MMP-2 production,
impaired wound healing repair, and decreased myotubes formation. Therefore
we conclude that loss of KCa1.1 and up-regulation of Kv1 channels in DM1
impairs early stage of myogenesis and can be partially rescued by modulating
such Kþ channels.
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The Smith-Lemli-Opitz syndrome (SLO) is a multiple congenital anomaly,
caused by a decreased or abolished activity of 7-dehydrocholesterol (7DHC)
reductase, which results in the accumulation of the cholesterol precursor
7DHC in the serum and potentially in the cell membrane as well. Increased
7DHC/cholesterol ratio may modify the physico-chemical properties of plasma
membrane, and hence may influence the operation of the ion channels in many
cell types including T cells. To test this hypothesis we compared the biophys-
ical properties of Kv1.3 channels in T cells of SLO patients (SLO-T-cells),
T-cells of healthy volunteers loaded with 7DHC (7DHC-T-cells) and control
T cells. The physiological consequence of altered Kv1.3 gating was measured
by the proliferative capacity of CD3þ lymphocytes.
T lymphocytes were isolated from the peripheral blood of healthy volunteers
(age-matched controls) and patients with SLO. 7DHC elevation in T lympho-
cytes membrane was achieved upon treatment with cyclodextrin/7DHC
complex. Kv1.3 currents were measured using whole-cell patch-clamp. Prolif-
eration rate of lymphocytes was assessed with CFSE-dilution assay upon anti-
CD3/anti-CD28 stimulation.
Our results showed that both activation and inactivation kinetics were signifi-
cantly slower, and the midpoint of the steady-state activation was shifted
toward positive voltages in the SLO-T-cells compared to control (taua,SLO:
0.72 ms, taua,c: 0.60 ms ; taui,SLO: 238,48 ms, taui,c : 213,19 ms; V1/2,SLO : -
21.762 mV ,V1/2,c : - 27.98 mV). Qualitatively and quantitatively differences
in the gating of Kv1.3 channels were observed in 7DHC-T-cells vs. control.
T-cells from SLO patients had decreased proliferation rate as compared to
healthy controls. These data demonstrate that elevated 7DHC level of cell
membrane can modify the operation of ion channels and may contribute to
the neurodegenerative defects in SLO. (Mecenatura OSTRAT/260/2012,
TA´MOP 4.2.4.A/2-11-1-2012-0001).2789-Pos Board B481
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The causative agent of malaria is the unicellular protozoan Plasmodium. The
parasite has a complex life cycle, involving asexual replication in human red
blood cells (RBCs) as well as sexual replication, forming egg-like cells called
oocysts in the mosquito vector. In endemic areas it is estimated that 250 million
people get infected with malaria annually, resulting in 500.000-1.000.000
deaths. Increasing resistance towards known antimalarial drugs poses a signif-
icant problem in the fight against malaria. Therefore, the development of novel
drugs that target vital proteins encoded by the parasite has attracted major atten-
tion. Plasmodium falciparum, the species responsible for the majority of
malaria- associated fatalities, encodes two putative Kþ channels, PfKch1 and
PfKch2, which have been cloned in our laboratories. Although viable in all
intraerythrocytic stages, Kch1-null P. berghei parasites exhibit a total inhibition
of oocyst development in the mosquito midgut. Thus, Kch1 might serve as a
potential target in novel parasite transmission-blocking strategies. However,
earlier published immunofluorescence microscopy images have suggested
that Kch1 is located in the infected human red blood cell membrane. In the pre-
sent study, polyclonal antibodies were raised against the PfKch1 channel and
our results demonstrate that Kch1 is located in the parasites plasma membrane
in all blood stages of malaria. This finding is in accordance with functional data
previously published from our lab. Thus, Kch1 may be a major Kþ transporter
in the parasite plasma membrane and play an important role for regulation of
the membrane potential of the Plasmodium parasite.
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Acute lymploblastic leukemia (ALL) is the most common malignancy in child-
hood and young adolescence, comprising about 30% of all cancers. Despite the
fact that treatment strategies have strongly improved in the last decades, ALL is
still one of the major causes of cancer-related death in children. Whilst the sub-
types of ALL deriving from B cells are already well described by their genetic
and molecular features, the biology of the T cell-linage (T-ALL) is very hetero-
geneous and with the exception of some frequently occurring genetic aberra-
tions until now poorly understood.
By controlling the membrane potential, Kþ channels regulate Ca2þ signaling
and subsequent proliferation in human lymphocytes. Expression levels of the
two major Kþ channels found in lymphocytes (Kv1.3 and KCa3.1) are
subtype-specific. The more abundantly expressed channel typically dominates
the Ca2þ signaling events that result in proliferation. This renders the cells
sensitive to specific blockade of this more highly expressed Kþ channel. We
investigated lymph node and bone marrow samples of T-ALL patients and
found high expression levels of Kv1.3 channels in malignant T-lymphoblasts,
confirmed by immunohistochemistry and immunofluorescence microscopy.
Moreover, we also detected high Kv1.3 currents in a T-ALL cell line
(Molt-4) compared to low KCa.3.1 currents, which was confirmed by mRNA
data, as well as fluorescence microscopy. The functional role of Kv1.3 in pro-
liferation of malignant T-lymphoblasts was elucidated by the pharmacological
blockade of Kv1.3. Proliferation rates were significantly diminished by treat-
ment with PAP-1 and ShK-L5 (specific blockers for Kv1.3 channels) but not
by TRAM-34 or ICA-17043 (specific blockers for KCa3.1). Further investiga-
tion might thus suggest a role for Kv1.3 channels in the treatment of T-ALL.
Supported by RO1 GM076063 from the National Institute of Health and the
Austrian National Bank Jubilaeumsfons No. 14311.
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Ion channel inhibitor peptide toxins have become lead compounds for potential
therapeutic use in the last decade. In the case of Kv1.3, the voltage-gated Kþ
